View in EDS HTML Full Text PDF Full Text

Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting.

Saved in:
Bibliographic Details
Title: Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting.
Authors: Danysh HE; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, 307 Waverley Oaks Road, Suite 101, Waltham, MA, 02452-8413, USA. hdanysh@rti.org., Johannes CB; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, 307 Waverley Oaks Road, Suite 101, Waltham, MA, 02452-8413, USA., Beachler DC; Department of Safety and Epidemiology, HealthCore, Inc., Wilmington, DE, USA., Layton JB; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA., Ziemiecki R; Department of Biostatistics, RTI Health Solutions, Research Triangle Park, NC, USA., Arana A; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain., Dinh J; Department of Research Operations, HealthCore, Inc., Wilmington, DE, USA., Li L; Department of Safety and Epidemiology, HealthCore, Inc., Wilmington, DE, USA., Calingaert B; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA., Pladevall-Vila M; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain.; The Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA., Hunt PR; BioPharmaceuticals Business Unit, AstraZeneca, Gaithersburg, MD, USA., Chen H; BioPharmaceuticals Business Unit, AstraZeneca, Gaithersburg, MD, USA., Karlsson C; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Johnsson K; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Gilsenan A; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA.
Source: Drug safety [Drug Saf] 2023 Feb; Vol. 46 (2), pp. 175-193. Date of Electronic Publication: 2022 Dec 30.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36583828
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Danysh+HE%22">Danysh HE</searchLink>; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, 307 Waverley Oaks Road, Suite 101, Waltham, MA, 02452-8413, USA. hdanysh@rti.org.<br /><searchLink fieldCode="AU" term="%22Johannes+CB%22">Johannes CB</searchLink>; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, 307 Waverley Oaks Road, Suite 101, Waltham, MA, 02452-8413, USA.<br /><searchLink fieldCode="AU" term="%22Beachler+DC%22">Beachler DC</searchLink>; Department of Safety and Epidemiology, HealthCore, Inc., Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Layton+JB%22">Layton JB</searchLink>; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA.<br /><searchLink fieldCode="AU" term="%22Ziemiecki+R%22">Ziemiecki R</searchLink>; Department of Biostatistics, RTI Health Solutions, Research Triangle Park, NC, USA.<br /><searchLink fieldCode="AU" term="%22Arana+A%22">Arana A</searchLink>; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Dinh+J%22">Dinh J</searchLink>; Department of Research Operations, HealthCore, Inc., Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Li+L%22">Li L</searchLink>; Department of Safety and Epidemiology, HealthCore, Inc., Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Calingaert+B%22">Calingaert B</searchLink>; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA.<br /><searchLink fieldCode="AU" term="%22Pladevall-Vila+M%22">Pladevall-Vila M</searchLink>; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain.; The Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA.<br /><searchLink fieldCode="AU" term="%22Hunt+PR%22">Hunt PR</searchLink>; BioPharmaceuticals Business Unit, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Chen+H%22">Chen H</searchLink>; BioPharmaceuticals Business Unit, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Karlsson+C%22">Karlsson C</searchLink>; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Johnsson+K%22">Johnsson K</searchLink>; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Gilsenan+A%22">Gilsenan A</searchLink>; Department of Pharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229002928%22">Drug safety</searchLink> [Drug Saf] 2023 Feb; Vol. 46 (2), pp. 175-193. <i>Date of Electronic Publication: </i>2022 Dec 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9002928 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1942 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201145916%22">01145916 </searchLink><i>NLM ISO Abbreviation: </i>Drug Saf <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36583828
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40264-022-01262-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 175
    Titles:
      – TitleFull: Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Danysh HE
      – PersonEntity:
          Name:
            NameFull: Johannes CB
      – PersonEntity:
          Name:
            NameFull: Beachler DC
      – PersonEntity:
          Name:
            NameFull: Layton JB
      – PersonEntity:
          Name:
            NameFull: Ziemiecki R
      – PersonEntity:
          Name:
            NameFull: Arana A
      – PersonEntity:
          Name:
            NameFull: Dinh J
      – PersonEntity:
          Name:
            NameFull: Li L
      – PersonEntity:
          Name:
            NameFull: Calingaert B
      – PersonEntity:
          Name:
            NameFull: Pladevall-Vila M
      – PersonEntity:
          Name:
            NameFull: Hunt PR
      – PersonEntity:
          Name:
            NameFull: Chen H
      – PersonEntity:
          Name:
            NameFull: Karlsson C
      – PersonEntity:
          Name:
            NameFull: Johnsson K
      – PersonEntity:
          Name:
            NameFull: Gilsenan A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2023 Feb
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1942
          Numbering:
            – Type: volume
              Value: 46
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Drug safety
              Type: main
ResultId 1